PL3522927T3 - Sposoby hamowania przemiany choliny w trimetyloaminę (tma) - Google Patents

Sposoby hamowania przemiany choliny w trimetyloaminę (tma)

Info

Publication number
PL3522927T3
PL3522927T3 PL18792735T PL18792735T PL3522927T3 PL 3522927 T3 PL3522927 T3 PL 3522927T3 PL 18792735 T PL18792735 T PL 18792735T PL 18792735 T PL18792735 T PL 18792735T PL 3522927 T3 PL3522927 T3 PL 3522927T3
Authority
PL
Poland
Prior art keywords
tma
trimethylamine
choline
methods
inhibiting conversion
Prior art date
Application number
PL18792735T
Other languages
English (en)
Inventor
Jose Carlos Garcia-Garcia
George Franklin Gerberick
Stanley Leon Hazen
Xiaodong Gu
Original Assignee
The Procter & Gamble Company
The Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company, The Cleveland Clinic Foundation filed Critical The Procter & Gamble Company
Publication of PL3522927T3 publication Critical patent/PL3522927T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL18792735T 2017-10-02 2018-10-02 Sposoby hamowania przemiany choliny w trimetyloaminę (tma) PL3522927T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762567010P 2017-10-02 2017-10-02
EP18792735.5A EP3522927B1 (en) 2017-10-02 2018-10-02 Methods for inhibiting conversion of choline to trimethylamine (tma)
PCT/US2018/053929 WO2019070678A1 (en) 2017-10-02 2018-10-02 METHODS OF INHIBITING CONVERSION FROM CHOLINE TO TRIMETHYLAMINE (TMA)

Publications (1)

Publication Number Publication Date
PL3522927T3 true PL3522927T3 (pl) 2021-06-28

Family

ID=63963529

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18792735T PL3522927T3 (pl) 2017-10-02 2018-10-02 Sposoby hamowania przemiany choliny w trimetyloaminę (tma)

Country Status (8)

Country Link
US (1) US10849866B2 (pl)
EP (1) EP3522927B1 (pl)
CN (1) CN111344016B (pl)
AU (1) AU2018345749B2 (pl)
CA (1) CA3076235C (pl)
MX (1) MX390466B (pl)
PL (1) PL3522927T3 (pl)
WO (1) WO2019070678A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3117566C (en) 2018-11-06 2024-04-09 The Procter & Gamble Company Methods for inhibiting conversion of choline to trimethylamine (tma)
US12162902B2 (en) * 2018-12-06 2024-12-10 Sail Biomedicines Decarboxylase inhibitors for treating Parkinson's disease
CN112029818A (zh) * 2020-09-18 2020-12-04 中国药科大学 一种利用微生物筛选三甲胺裂解酶抑制剂的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1542826B1 (de) 1966-06-01 1971-04-08 Basf Ag Sulfoniumverbindungen und deren Verwendung
FR1559102A (pl) 1968-01-23 1969-03-07
US3644531A (en) 1968-08-13 1972-02-22 Sankyo Co 2-propynylsulfonium salts
US3651222A (en) 1969-09-15 1972-03-21 Monsanto Co Nematocidal use of substituted dimethylsulfonium tetraphenylborates
DE2331185A1 (de) 1973-06-19 1975-01-16 Bayer Ag Mittel zur regulierung des pflanzenwachstums
EP0555058B1 (en) 1992-02-07 1997-05-07 Toyo Ink Manufacturing Co., Ltd. (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition
WO2005009928A2 (en) * 2003-07-24 2005-02-03 The Queen's Medical Center Preparation and use of alkylating agents
JP4999043B2 (ja) 2006-02-13 2012-08-15 株式会社Adeka スルホニウム塩化合物、カチオン重合開始剤および熱硬化性組成物
EP2001484A4 (en) * 2006-03-22 2010-04-21 Harvard College METHOD AND COMPOSITIONS FOR TREATING HYPERCHOLESTERINEMIA AND ATHEROSCLEROSIS
WO2009073839A1 (en) 2007-12-05 2009-06-11 The Cleveland Clinic Foundation Trimethylamine compounds as risk predictors of cardiovascular disease
AU2013274406B2 (en) 2012-06-11 2017-02-02 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
WO2017095995A1 (en) 2015-12-01 2017-06-08 The Procter & Gamble Company Methods for inhibiting conversion of carnitine to trimethylamine (tma)
AU2017291211B2 (en) 2016-06-29 2020-06-25 Cleveland Clinic Innovation Methods for inhibiting conversion of choline to trimethylamine (TMA)

Also Published As

Publication number Publication date
CN111344016B (zh) 2022-04-05
WO2019070678A1 (en) 2019-04-11
US20190099390A1 (en) 2019-04-04
CA3076235C (en) 2022-06-21
MX2020003081A (es) 2022-03-07
MX390466B (es) 2025-03-12
EP3522927B1 (en) 2020-11-25
CA3076235A1 (en) 2019-04-11
US10849866B2 (en) 2020-12-01
AU2018345749B2 (en) 2021-03-11
AU2018345749A1 (en) 2020-04-09
CN111344016A (zh) 2020-06-26
EP3522927A1 (en) 2019-08-14
BR112020006085A2 (pt) 2020-09-29

Similar Documents

Publication Publication Date Title
PL3478276T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
PL3383376T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
IL257219B (en) Prodrugs of glutamine analogs
IL253503A0 (en) Allele-specific modulators of p23h rhodopsin
EP3212657A4 (en) Methods of preparing substituted nucleoside analogs
PL3221873T3 (pl) System do zabezpieczenia transformatorów typu suchego
GB201507524D0 (en) Improvements to molybdenum containing coatings
PT3334734T (pt) Forma c de avibactam sódico
HUE048433T2 (hu) Tökéletesítés kábeltálcák szakaszaihoz
SG11201706503TA (en) System for forming elastomeric compositions for application to metal
ZA201604588B (en) Pretreatment of substrates that have unsaturated units
IL266087A (en) Use of itolizumab to reduce cd6 phosphorylation
GB201607819D0 (en) Secure distribution of an image
PL3522927T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
GB201702388D0 (en) Compositions for application to aerial parts of plants
IL262111A (en) Monovalent inhibitors of hutnfr1 interaction
PL3522878T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
GB2555733B (en) Electrical isolation to reduce magnetometer interference
PL3522876T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
PT3393517T (pt) Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave
GB2528112B (en) Improvements relating to inhibition of corrosion
IL250846A0 (en) Synthesis of cyclocreatin and its analogs
GB2583579B (en) Echo cancellation for time of flight analogue to digital converter
GB2534560B (en) Preparation of Composite Substrates
GB201820351D0 (en) Preparation of composite substrates